OPS: 5-35a.01 OPS: 5-362.03 OPS: 5-35a.50
Conditions
Interventions
Group 1: Ropivacaine 0.2%, run rate 8ml/h=16mg/h, min. 24h, max. 43h until elastomer pump [volume 350ml] is empty
Group 2: NaCl solution 0.9%, run rate 8ml/h=16mg/h, min. 24h, max. 43h until elastomer
Sponsors
Universitätsklinikum Magdeburg Herz- und Thoraxchirurgie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients undergoing cardiac surgery with lateral minithoracotomy - Written informed consent of the study participants
Exclusion criteria
Exclusion criteria: • Lack of consent or capacity to consent on the part of the patient • Patients with chronic pain syndrome • previously known allergies to local anesthetics • Drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is the amount of piritramide administered within the first 6 hours postoperative. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. amount of piritramide administered within 12 hours and 24 hours postoperative 2. course of pain intensity during the inpatient stay (visual analog scale) 3. pain intensity 6 - 8 weeks postoperatively, determined by questionnaire (by post or telephone if it is not possible for patients to complete the questionnaire) 4. Duration of the intercostal catheter 5. complication rate and side effects of the intercostal catheter (infections, paresthesia) 6. duration of hospitalization 7. follow-up parameters of the hospital stay: laboratory values, data on the clinical course | — |
Countries
Germany
Contacts
Public ContactMax Wacker
Universitätsklinikum Magdeburg, Herz- und Thoraxchirurgie
Outcome results
None listed